Medicare Enrolled
Dr. Suprith Badarinath, MD
Hematology & Oncology · Jacksonville, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Badarinath from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Badarinath?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Badarinath
Dr. Suprith Badarinath is a hematology & oncology specialist in Jacksonville, FL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Badarinath performed 69,843 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Badarinath received a total of $2,215 from 40 pharmaceutical and/or device companies across 124 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Badarinath is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 12% volume in FL
$2,215 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗69,843
Medicare services
Top 12% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
42,000 | $1 | $4 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
15,500 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
3,660 | $6 | $27 |
| Denosumab injection (Prolia/Xgeva) | 1,560 | $18 | $38 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,258 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
969 | $8 | $18 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
869 | $8 | $41 |
| Anti-nausea injection (Aloxi/palonosetron) | 780 | $1 | $75 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
537 | $63 | $104 |
| Injection, granisetron hydrochloride, 100 mcg | 360 | $0 | $41 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
344 | $95 | $162 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
214 | $22 | $90 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
173 | $94 | $355 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
163 | $12 | $55 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
154 | $62 | $115 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
144 | $10 | $42 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
131 | $53 | $500 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
99 | $165 | $535 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
85 | $48 | $160 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
79 | $48 | $310 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
77 | $20 | $80 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
73 | $5 | $29 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
59 | $1 | $4 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
51 | $73 | $270 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
49 | $49 | $175 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
49 | $135 | $330 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
45 | $70 | $70 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
43 | $4 | $20 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
43 | $6 | $35 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
34 | $4 | $55 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
30 | $140 | $235 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 28 | $374 | $1,000 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
24 | $1,012 | $2,400 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
23 | $10 | $40 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $125 | $265 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $103 | $225 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
22 | $2 | $97 |
| New patient office visit, complex (60-74 min) | 15 | $165 | $340 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
15 | $37 | $68 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
14 | $94 | $160 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $82 | $181 |
| CT scan of neck soft tissue with contrast A computed tomography scan that uses contrast dye to create detailed images of the soft tissues in the neck. |
12 | $67 | $495 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
60.9% high complexity
34.3% medium
4.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,215
Total received (2018-2024)
Avg $316/year across 7 years
Bottom 39% in FL for hematology & oncology
40
Companies
124
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$421
2023
$147
2022
$144
2021
$530
2020
$184
2019
$444
2018
$345
Payments by company (2024)
Genmab U.S., Inc.
$111
Novartis Pharmaceuticals Corporation
$108
Janssen Biotech, Inc.
$51
TAIHO ONCOLOGY, INC.
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
INTUITIVE SURGICAL, INC.
$18
Astellas Pharma US Inc
$17
ARRAY BIOPHARMA INC
$14
Mirati Therapeutics, Inc.
$14
Exelixis Inc.
$14
E.R. Squibb & Sons, L.L.C.
$14
Top 3 companies account for 64.1% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$342
Novartis Pharmaceuticals Corporation
$199
PFIZER INC.
$177
Taiho Oncology, Inc.
$157
Janssen Biotech, Inc.
$136
Genmab U.S., Inc.
$111
Exelixis Inc.
$91
Foundation Medicine, Inc.
$89
Janssen Scientific Affairs, LLC
$84
Janssen Pharmaceuticals, Inc
$70
Sunovion Pharmaceuticals Inc.
$68
Alexion Pharmaceuticals, Inc.
$56
Incyte Corporation
$52
Genentech USA, Inc.
$50
TAIHO ONCOLOGY, INC.
$41
AbbVie Inc.
$37
GENZYME CORPORATION
$34
Merck Sharp & Dohme Corporation
$31
Takeda Pharmaceuticals U.S.A., Inc.
$30
Mirati Therapeutics, Inc.
$29
TG THERAPEUTICS, INC.
$26
Puma Biotechnology, Inc.
$25
E.R. Squibb & Sons, L.L.C.
$25
Gilead Sciences, Inc.
$24
EKOS Corporation
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
INTUITIVE SURGICAL, INC.
$18
EISAI INC.
$16
Merck Sharp & Dohme LLC
$16
AstraZeneca Pharmaceuticals LP
$16
CTI BioPharma Corp.
$15
ARRAY BIOPHARMA INC
$14
Aurobindo Pharma USA, Inc.
$14
Daiichi Sankyo Inc.
$13
Eisai Inc.
$13
Karyopharm Therapeutics Inc.
$12
MorphoSys, US Inc.
$12
Lilly USA, LLC
$11
TESARO, Inc.
$11
Sirtex Medical Inc
$9
Top 3 companies account for 32.4% of all-time payments
Associated products mentioned in payments ›
CABLIVI · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · Da Vinci Surgical System · EKOSONIC · ERLEADA · Epkinly · Erleada · FOUNDATIONONE · Fabhalta · Folotyn · Herceptin · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · LONHALA MAGNAIR · LONSURF · LORBRENA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · NINLARO · Nerlynx · OCREVUS · OPDIVO · PADCEV · PIQRAY · PLUVICTO · PROMACTA · Padcev · RYBREVANT · SIR-Spheres Microspheres · SOLIRIS · SUTENT · TABRECTA · TASIGNA · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · Utibron · VENCLEXTA · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
106
County median income
$68,447
Nearest hospital to ZIP centroid (approximate)
ASCENSION ST VINCENT'S RIVERSIDE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Badarinath is a mixed practice specialist, with above-average Medicare volume (top 12% in FL), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Badarinath experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Badarinath performed 42,000 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Badarinath receive payments from pharmaceutical companies?
Yes. Dr. Badarinath received a total of $2,215 from 40 companies across 124 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Badarinath's costs compare to other hematology & oncology specialists in Jacksonville?
Dr. Badarinath's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Badarinath) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Jacksonville
Browse hematology & oncology specialists in Jacksonville ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology